207 related articles for article (PubMed ID: 31499506)
1. Androgens in Congenital Adrenal Hyperplasia.
Pignatelli D; Pereira SS; Pasquali R
Front Horm Res; 2019; 53():65-76. PubMed ID: 31499506
[TBL] [Abstract][Full Text] [Related]
2. Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report.
Sumińska M; Bogusz-Górna K; Wegner D; Fichna M
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610579
[TBL] [Abstract][Full Text] [Related]
3. [Congenital adrenal hyperplasia].
Stanić M; Nesović M
Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
[TBL] [Abstract][Full Text] [Related]
4. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
Jones CM; Mallappa A; Reisch N; Nikolaou N; Krone N; Hughes BA; O'Neil DM; Whitaker MJ; Tomlinson JW; Storbeck KH; Merke DP; Ross RJ; Arlt W
J Clin Endocrinol Metab; 2017 Jun; 102(6):1797-1806. PubMed ID: 27845856
[TBL] [Abstract][Full Text] [Related]
5. Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia.
Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
J Steroid Biochem Mol Biol; 2018 Apr; 178():221-228. PubMed ID: 29277706
[TBL] [Abstract][Full Text] [Related]
6. Androgen synthesis in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Kamrath C; Hartmann MF; Wudy SA
Horm Metab Res; 2013 Feb; 45(2):86-91. PubMed ID: 23345132
[TBL] [Abstract][Full Text] [Related]
7. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.
Lobo RA; Goebelsmann U
Am J Obstet Gynecol; 1980 Nov; 138(6):720-6. PubMed ID: 6254362
[TBL] [Abstract][Full Text] [Related]
8. 11-Oxygenated androgens in health and disease.
Turcu AF; Rege J; Auchus RJ; Rainey WE
Nat Rev Endocrinol; 2020 May; 16(5):284-296. PubMed ID: 32203405
[TBL] [Abstract][Full Text] [Related]
9. Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.
Newfield RS; Sarafoglou K; Fechner PY; Nokoff NJ; Auchus RJ; Vogiatzi MG; Jeha GS; Giri N; Roberts E; Sturgeon J; Chan JL; Farber RH
J Clin Endocrinol Metab; 2023 Oct; 108(11):2871-2878. PubMed ID: 37216921
[TBL] [Abstract][Full Text] [Related]
10. 11-oxygenated androgens and their relation to hypothalamus-pituitary-gonadal-axis disturbances in adults with congenital adrenal hyperplasia.
Auer MK; Paizoni L; Neuner M; Lottspeich C; Schmidt H; Bidlingmaier M; Hawley J; Keevil B; Reisch N
J Steroid Biochem Mol Biol; 2021 Sep; 212():105921. PubMed ID: 34058329
[TBL] [Abstract][Full Text] [Related]
11. Back where it belongs: 11β-hydroxyandrostenedione compels the re-assessment of C11-oxy androgens in steroidogenesis.
Barnard L; du Toit T; Swart AC
Mol Cell Endocrinol; 2021 Apr; 525():111189. PubMed ID: 33539964
[TBL] [Abstract][Full Text] [Related]
12. Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.
Miller WL
Horm Res Paediatr; 2019; 91(6):416-420. PubMed ID: 31450227
[TBL] [Abstract][Full Text] [Related]
13. Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency.
Bacila I; Adaway J; Hawley J; Mahdi S; Krone R; Patel L; Alvi S; Randell T; Gevers E; Dattani M; Cheetham T; Kyriakou A; Schiffer L; Ryan F; Crowne E; Davies JH; Ahmed SF; Keevil B; Krone N
J Clin Endocrinol Metab; 2019 Dec; 104(12):6417-6429. PubMed ID: 31361321
[TBL] [Abstract][Full Text] [Related]
14. The adrenal cortex and virilization.
McKenna TJ; Cunningham SK; Loughlin T
Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
[TBL] [Abstract][Full Text] [Related]
15. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.
Carmina E; Dewailly D; Escobar-Morreale HF; Kelestimur F; Moran C; Oberfield S; Witchel SF; Azziz R
Hum Reprod Update; 2017 Sep; 23(5):580-599. PubMed ID: 28582566
[TBL] [Abstract][Full Text] [Related]
16. Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia.
Nowotny HF; Auer MK; Lottspeich C; Schmidt H; Dubinski I; Bidlingmaier M; Adaway J; Hawley J; Keevil B; Reisch N
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4509-e4519. PubMed ID: 34165575
[TBL] [Abstract][Full Text] [Related]
17. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
Azziz R; Bradley EL; Potter HD; Boots LR
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
[TBL] [Abstract][Full Text] [Related]
18. The 21-hydroxylase-deficient adrenal hyperplasias: more than ACTH oversecretion.
Azziz R; Slayden SM
J Soc Gynecol Investig; 1996; 3(6):297-302. PubMed ID: 8923412
[TBL] [Abstract][Full Text] [Related]
19. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
[TBL] [Abstract][Full Text] [Related]
20. The ratio of androstenedione:11 beta-hydroxyandrostenedione is an important marker of adrenal androgen excess in women.
Carmina E; Stanczyk FZ; Chang L; Miles RA; Lobo RA
Fertil Steril; 1992 Jul; 58(1):148-52. PubMed ID: 1623996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
